Anisimov, Vladimir N.
November 2013
Cell Cycle;11/15/2013, Vol. 12 Issue 22, p3483
Academic Journal
No abstract available.


Related Articles

  • metformin.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1456 

    A definition of the term "metformin" is presented.

  • Metformin in patients with congestive heart failure. Deblinger, Larry // Patient Care for the Nurse Practitioner;Sep2001, Vol. 4 Issue 9, p12 

    Focuses on the application of metformin in patients with congestive heart failure. Adverse effect of metformin; Risk of metformin-associated lactic acidosis; Indications for metformin.

  • Metformin.  // Reactions Weekly;Jul2014, Vol. 1510 Issue 1, p29 

    An abstract of the article "Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation," by J. D. Lalau and colleagues is presented.

  • Metformin Hepatotoxicity. Deutsch, M.; Kountouras, D.; Dourakis, S. P. // Annals of Internal Medicine;3/2/2004, Vol. 140 Issue 5, p408 

    Presents a letter to the editor about metformin hepatotoxicity.

  • Unexpected recovery from prolonged hypoglycemic coma: a protective role of metformin? Lalau, Jean-Daniel; Masmoudi, Kamel // Intensive Care Medicine;Mar2005, Vol. 31 Issue 3, p493 

    Presents a letter to the editor discussing the protective role of metformin.

  • Metformin Helps Patients with Polycystic Ovary Syndrome. Walling, Anne D. // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2217 

    Deals with a study conducted on the effectiveness of metformin in the treatment of polycystic ovary syndrome. Comparison between metformin therapy and placebo treatment; Association of metformin therapy with systolic and diastolic blood pressures; Impact of metformin treatment on weight loss.

  • Metformin allergy. Wiwanitkit, Viroj // Indian Journal of Pharmacology;Apr2011, Vol. 43 Issue 2, p216 

    Metformin is an important antidiabetic agent that is widely used for diabetic patients. Here, a case of metformin allergy, presenting with skin lesions, is reported.

  • Metformin attenuates cardiac fibrosis by inhibiting the TGFβ1–Smad3 signalling pathway. Han Xiao; Xiaowei Ma; Wei Feng; Yongnan Fu; Zhizhen Lu; Ming Xu; Qiang Shen; Yi Zhu; Youyi Zhang // Cardiovascular Research;Aug2010, Vol. 87 Issue 3, p504 

    Aims: The mechanism of the cardioprotective action of metformin is incompletely understood. We determined the role of metformin in cardiac fibrosis and investigated the mechanism.

  • `Can I use metformin?'. Barzilai, Nir; Engel, Samuel // Diabetes Forecast;Nov96, Vol. 49 Issue 11, p28 

    Answers some of the more common questions asked about the use of metformin to control diabetes. Includes questions on metformin's similarity with other diabetes pills; Conditions when metformin use is recommended; Safety concerns and issues; People at risk for acidosis from metformin use. ...

  • When should we use metformin in PCOS? Franks, Stephen // Pulse;11/3/2003, Vol. 63 Issue 44, p96 

    Determines which women with polycystic ovary syndrome (PCOS) should receive metformin. Lack of randomized controlled trials to assess efficacy of metformin; Support for the notion that metformin improves the frequency of ovulation.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics